Join our daily newsletter At The Bell to receive exclusive market insights
- Pro Medicus (PME) subsidiary Visage Imaging has signed a $14 million, eight-year contract with the University of Vermont Health Network
- The contract will see the company’s Visage 7 diagnostic imaging platform implemented across the university’s six hospitals
- Notably, Visage 7 will be fully deployed in the public cloud
- Planning for the rollout is set to commence immediately, with initial “go-lives” targeted for the second half of the calendar year
- Pro Medicus shares are up 1.45 per cent, trading at $41.15 cents each
Pro Medicus’ (PME) wholly owned subsidiary Visage Imaging has signed a $14 million, eight-year contract with the University of Vermont Health Network.
Based on a transactional licensing model, the contract will see the company’s Visage 7 enterprise diagnostic imaging platform implemented across UVM’s six hospitals.
Notably, the University’s medical centre in Burlington, Vermont, is the teaching hospital for The Larner College of Medicine.
Pro Medicus CEO Dr Sam Hupert said the platform would be deployed in the public cloud.
“We continue to build momentum in the market with this, our seventh contract win in a row, adding to other recent major announcements,” Dr Hupert said
“UVM Health Network is the fourth of these to opt for a cloud-based solution, a trend we see increasing rapidly amongst healthcare systems in North America.”
“Visage 7, with its proven cloud-native capability provides us with a significant strategic advantage that enables us to address these opportunities across a growing segment of the market both in North America and other regions.”
Planning for the rollout is set to commence immediately, with initial “go-lives” targeted for the second half of the calendar year.
On the back of the announcement, Pro Medicus shares are trading 1.45 per cent higher at $41.15 cents at 12:34 pm AEST.
